Skip to Main Content
Table 3—

RH and 95% CI for all-cause and CVD mortality for 1 SD increment in plasma glucose for 3,092 adults aged 30–74 years in NHANES II

All-cause mortality
CVD Mortality
Fasting glucose2-h glucoseFasting glucose2-h glucose
Model 1     
 RH* 1.10 1.14 1.09 1.13 
 95% CI 1.00–1.22 1.00–1.29 0.95–1.25 0.93–1.38 
P value β 0.02 0.03 0.56 0.61 
Model 2     
 RH* 1.05 1.10 1.02 1.07 
 95% CI 0.89–1.23 0.91–1.33 0.79–1.32 0.78–1.46 
P value β 0.37 0.59 0.85 0.67 
All-cause mortality
CVD Mortality
Fasting glucose2-h glucoseFasting glucose2-h glucose
Model 1     
 RH* 1.10 1.14 1.09 1.13 
 95% CI 1.00–1.22 1.00–1.29 0.95–1.25 0.93–1.38 
P value β 0.02 0.03 0.56 0.61 
Model 2     
 RH* 1.05 1.10 1.02 1.07 
 95% CI 0.89–1.23 0.91–1.33 0.79–1.32 0.78–1.46 
P value β 0.37 0.59 0.85 0.67 

Model 1, proportional hazards model adjusts for either fasting or 2-h glucose; model 2, proportional hazards model adjusts for fasting and 2-h glucose simultaneously. SD for fasting glucose 1.18 mmol/l and for 2-h glucose 3.18 mmol/l.

*

Adjusted for age (continuous), sex, race (white, nonwhite), education (<high school, ≥high school), smoking (ever, never), physical activity (low, high), BMI (<25, 25≤ to <27, 27≤ to <30, ≥30 kg/m2), systolic blood pressure, total cholesterol–to–HDL cholesterol ratio (continuous).

Close Modal

or Create an Account

Close Modal
Close Modal